Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1999 2
2001 1
2004 2
2005 2
2006 2
2011 2
2012 1
2019 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Hypereosinophilic syndrome: an update.
Wilkins HJ, Crane MM, Copeland K, Williams WV. Wilkins HJ, et al. Am J Hematol. 2005 Oct;80(2):148-57. doi: 10.1002/ajh.20423. Am J Hematol. 2005. PMID: 16184589 Free article. Review.
Emerging therapeutic targets in psoriasis.
Bayliffe AI, Brigandi RA, Wilkins HJ, Levick MP. Bayliffe AI, et al. Among authors: wilkins hj. Curr Opin Pharmacol. 2004 Jun;4(3):306-10. doi: 10.1016/j.coph.2004.02.003. Curr Opin Pharmacol. 2004. PMID: 15140425 Review.
Physician-owned groups: the best strategy for success.
Wilkins HJ, Pierotti RJ, Motley RJ, Cohan HD, Conrad JL, Derstine RL, Mertzanis P, Bender AD. Wilkins HJ, et al. Fam Pract Manag. 1999 May;6(5):38-41. Fam Pract Manag. 1999. PMID: 10537796 Free article. Review. No abstract available.
Phase 1 Open-Label, Multicenter Study of First-in-Class RORγ Agonist LYC-55716 (Cintirorgon): Safety, Tolerability, and Preliminary Evidence of Antitumor Activity.
Mahalingam D, Wang JS, Hamilton EP, Sarantopoulos J, Nemunaitis J, Weems G, Carter L, Hu X, Schreeder M, Wilkins HJ. Mahalingam D, et al. Among authors: wilkins hj. Clin Cancer Res. 2019 Jun 15;25(12):3508-3516. doi: 10.1158/1078-0432.CCR-18-3185. Epub 2019 Feb 28. Clin Cancer Res. 2019. PMID: 30819679 Clinical Trial.
A new direction.
Wilkins HJ. Wilkins HJ. Fam Pract Manag. 2001 Nov-Dec;8(10):12. Fam Pract Manag. 2001. PMID: 11757232 Free article. No abstract available.
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.
Spergel JM, Rothenberg ME, Collins MH, Furuta GT, Markowitz JE, Fuchs G 3rd, O'Gorman MA, Abonia JP, Young J, Henkel T, Wilkins HJ, Liacouras CA. Spergel JM, et al. Among authors: wilkins hj. J Allergy Clin Immunol. 2012 Feb;129(2):456-63, 463.e1-3. doi: 10.1016/j.jaci.2011.11.044. Epub 2011 Dec 28. J Allergy Clin Immunol. 2012. PMID: 22206777 Clinical Trial.
15 results